Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands

Details for Australian Patent Application No. 2008202190 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Strupczewski, Joseph T.; Shutske, Gregory; Hemmerle, Horst; Zhao, XuYang; Jurcak, John G.; Urmann, Matthias; Mueller, Paul J.; Weiberth, Franz Jr.; Gill, Harpa; Bordeau, Kenneth J.; Hendrix, James A.; Jackson, Sharon A.; Nieduzak, Thaddeus

Agent Watermark

Pub. Number AU-A-2008202190

Parent 2002252009

Filing date 16 May 2008

Wipo publication date 5 June 2008

International Classifications

C07D 295/12 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4535 (2006.01)

A61K 31/454 (2006.01)

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/497 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 31/5377 (2006.01)

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 June 2008 Application Open to Public Inspection

  Published as AU-A-2008202190

5 June 2008 Complete Application Filed

9 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202191-Container Handle and Related Methods

2008202189-System and method for independently authorizing auxiliary communication services